Capricor Therapeutics Stock Price History
| CAPR Stock | USD 18.62 0.83 4.67% |
Below is the normalized historical share price chart for Capricor Therapeutics extending back to June 20, 2002. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Capricor Therapeutics stands at 18.62, as last reported on the 23rd of November, with the highest price reaching 18.88 and the lowest price hitting 17.51 during the day.
If you're considering investing in Capricor Stock, it is important to understand the factors that can impact its price. Capricor Therapeutics is slightly risky given 3 months investment horizon. Capricor Therapeutics secures Sharpe Ratio (or Efficiency) of 0.23, which signifies that the company had a 0.23% return per unit of risk over the last 3 months. We were able to interpolate data for thirty different technical indicators, which can help you to evaluate if expected returns of 2.6% are justified by taking the suggested risk. Use Capricor Therapeutics Downside Deviation of 5.05, risk adjusted performance of 0.1912, and Mean Deviation of 6.81 to evaluate company specific risk that cannot be diversified away.
At this time, Capricor Therapeutics' Total Stockholder Equity is relatively stable compared to the past year. As of 11/23/2024, Common Stock Shares Outstanding is likely to grow to about 28.1 M, while Common Stock is likely to drop slightly above 20.7 K. . At this time, Capricor Therapeutics' Price Book Value Ratio is relatively stable compared to the past year. As of 11/23/2024, Price Earnings To Growth Ratio is likely to grow to 0.21, while Price Earnings Ratio is likely to drop (6.17). Capricor Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 13th of February 2007 | 200 Day MA 7.9493 | 50 Day MA 16.6248 | Beta 4.016 |
Capricor |
Sharpe Ratio = 0.23
| Best Portfolio | Best Equity | |||
| Good Returns | CAPR | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 11.3 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.6 actual daily | 51 51% of assets have lower returns |
Risk-Adjusted Return
| 0.23 actual daily | 18 82% of assets perform better |
Based on monthly moving average Capricor Therapeutics is performing at about 18% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Capricor Therapeutics by adding it to a well-diversified portfolio.
Price Book 12.4024 | Enterprise Value Ebitda (2.73) | Price Sales 36.4495 | Shares Float 25.7 M | Wall Street Target Price 41.2857 |
Capricor Therapeutics Stock Price History Chart
There are several ways to analyze Capricor Stock price data. The simplest method is using a basic Capricor candlestick price chart, which shows Capricor Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | October 29, 2024 | 21.99 |
| Lowest Price | September 6, 2024 | 4.08 |
Capricor Therapeutics November 23, 2024 Stock Price Synopsis
Various analyses of Capricor Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Capricor Stock. It can be used to describe the percentage change in the price of Capricor Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Capricor Stock.| Capricor Therapeutics Price Action Indicator | 0.84 | |
| Capricor Therapeutics Price Rate Of Daily Change | 1.05 | |
| Capricor Therapeutics Price Daily Balance Of Power | 0.61 |
Capricor Therapeutics November 23, 2024 Stock Price Analysis
Capricor Stock Price History Data
The price series of Capricor Therapeutics for the period between Sun, Aug 25, 2024 and Sat, Nov 23, 2024 has a statistical range of 17.91 with a coefficient of variation of 50.75. The prices are distributed with arithmetic mean of 13.67. The median price for the last 90 days is 17.77. The company had 1:10 stock split on 5th of June 2019. Capricor Therapeutics issued dividends on 2019-06-05.| Open | High | Low | Close | Volume | ||
11/23/2024 | 17.94 | 18.88 | 17.51 | 18.62 | ||
| 11/22/2024 | 17.94 | 18.88 | 17.51 | 18.62 | 1,000,371 | |
| 11/21/2024 | 18.76 | 20.03 | 17.02 | 17.79 | 2,198,724 | |
| 11/20/2024 | 18.39 | 19.39 | 18.22 | 18.92 | 818,152 | |
| 11/19/2024 | 18.08 | 19.09 | 18.04 | 18.46 | 704,767 | |
| 11/18/2024 | 18.66 | 19.47 | 17.21 | 18.38 | 1,216,193 | |
| 11/15/2024 | 18.58 | 19.12 | 18.03 | 18.61 | 929,596 | |
| 11/14/2024 | 16.92 | 19.50 | 16.92 | 18.49 | 1,861,424 | |
| 11/13/2024 | 18.19 | 18.58 | 16.77 | 16.91 | 1,715,333 | |
| 11/12/2024 | 19.32 | 19.49 | 17.92 | 18.10 | 1,331,233 | |
| 11/11/2024 | 19.71 | 20.25 | 19.10 | 19.54 | 720,116 | |
| 11/08/2024 | 18.75 | 19.80 | 18.66 | 19.70 | 729,186 | |
| 11/07/2024 | 18.93 | 20.37 | 18.44 | 18.85 | 1,077,827 | |
| 11/06/2024 | 18.83 | 19.21 | 17.50 | 18.23 | 1,345,649 | |
| 11/05/2024 | 18.65 | 19.30 | 18.01 | 18.45 | 652,318 | |
| 11/04/2024 | 19.20 | 19.70 | 18.56 | 18.60 | 1,103,634 | |
| 11/01/2024 | 20.10 | 20.74 | 19.27 | 19.45 | 803,375 | |
| 10/31/2024 | 21.57 | 21.63 | 20.04 | 20.10 | 892,419 | |
| 10/30/2024 | 22.20 | 22.90 | 21.00 | 21.36 | 1,050,995 | |
| 10/29/2024 | 21.47 | 22.36 | 20.77 | 21.99 | 1,313,940 | |
| 10/28/2024 | 22.13 | 22.43 | 20.82 | 21.46 | 1,019,739 | |
| 10/25/2024 | 21.59 | 22.61 | 21.01 | 21.78 | 1,505,792 | |
| 10/24/2024 | 21.24 | 22.32 | 20.26 | 21.21 | 1,272,133 | |
| 10/23/2024 | 20.17 | 21.45 | 19.61 | 21.39 | 1,812,496 | |
| 10/22/2024 | 20.37 | 21.16 | 19.55 | 20.14 | 1,584,050 | |
| 10/21/2024 | 18.83 | 20.98 | 18.56 | 20.57 | 2,327,020 | |
| 10/18/2024 | 18.50 | 19.13 | 17.98 | 18.86 | 2,752,147 | |
| 10/17/2024 | 19.31 | 20.48 | 18.17 | 18.49 | 5,005,652 | |
| 10/16/2024 | 21.47 | 21.80 | 19.07 | 20.51 | 2,977,316 | |
| 10/15/2024 | 19.23 | 23.40 | 18.92 | 21.60 | 3,697,910 | |
| 10/14/2024 | 17.78 | 19.79 | 17.02 | 19.58 | 2,089,245 | |
| 10/11/2024 | 18.27 | 20.36 | 16.81 | 17.77 | 4,591,578 | |
| 10/10/2024 | 17.14 | 17.26 | 15.34 | 17.14 | 3,155,344 | |
| 10/09/2024 | 19.58 | 20.00 | 16.59 | 17.31 | 3,592,744 | |
| 10/08/2024 | 18.25 | 21.47 | 18.25 | 19.33 | 4,306,580 | |
| 10/07/2024 | 21.19 | 21.88 | 17.75 | 18.09 | 4,780,043 | |
| 10/04/2024 | 17.90 | 21.98 | 17.51 | 21.65 | 10,045,025 | |
| 10/03/2024 | 16.53 | 17.91 | 16.02 | 17.07 | 3,240,045 | |
| 10/02/2024 | 14.56 | 17.48 | 14.32 | 16.52 | 5,352,668 | |
| 10/01/2024 | 15.25 | 18.14 | 13.77 | 15.01 | 12,834,604 | |
| 09/30/2024 | 9.87 | 15.65 | 9.87 | 15.21 | 15,292,454 | |
| 09/27/2024 | 10.06 | 10.30 | 9.05 | 9.95 | 2,546,744 | |
| 09/26/2024 | 9.96 | 11.10 | 9.70 | 9.99 | 5,807,484 | |
| 09/25/2024 | 9.97 | 12.87 | 9.90 | 10.34 | 41,936,276 | |
| 09/24/2024 | 8.43 | 9.24 | 7.42 | 9.10 | 30,466,778 | |
| 09/23/2024 | 5.11 | 6.00 | 5.10 | 5.97 | 1,452,841 | |
| 09/20/2024 | 4.99 | 5.12 | 4.93 | 5.05 | 439,637 | |
| 09/19/2024 | 5.25 | 5.26 | 4.92 | 4.99 | 317,419 | |
| 09/18/2024 | 5.20 | 5.60 | 5.02 | 5.12 | 816,123 | |
| 09/17/2024 | 4.86 | 5.19 | 4.59 | 5.08 | 1,674,322 | |
| 09/16/2024 | 4.59 | 4.74 | 4.35 | 4.41 | 138,416 | |
| 09/13/2024 | 4.23 | 4.65 | 4.20 | 4.59 | 296,754 | |
| 09/12/2024 | 4.20 | 4.28 | 4.05 | 4.18 | 186,093 | |
| 09/11/2024 | 4.26 | 4.33 | 4.16 | 4.18 | 91,086 | |
| 09/10/2024 | 4.22 | 4.31 | 4.15 | 4.28 | 117,109 | |
| 09/09/2024 | 4.10 | 4.31 | 4.10 | 4.20 | 161,681 | |
| 09/06/2024 | 4.26 | 4.31 | 3.98 | 4.08 | 235,063 | |
| 09/05/2024 | 4.34 | 4.34 | 4.20 | 4.24 | 116,534 | |
| 09/04/2024 | 4.34 | 4.45 | 4.29 | 4.35 | 122,862 | |
| 09/03/2024 | 4.56 | 4.59 | 4.34 | 4.37 | 159,528 | |
| 08/30/2024 | 4.71 | 4.80 | 4.44 | 4.57 | 242,101 |
About Capricor Therapeutics Stock history
Capricor Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Capricor is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Capricor Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Capricor Therapeutics stock prices may prove useful in developing a viable investing in Capricor Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 26.8 M | 28.1 M | |
| Net Loss | -26.1 M | -24.8 M |
Capricor Therapeutics Stock Technical Analysis
Capricor Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
| All Next | Launch Module |
Capricor Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Capricor Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Capricor Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Capricor to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1912 | |||
| Jensen Alpha | 2.64 | |||
| Total Risk Alpha | 0.8845 | |||
| Sortino Ratio | 0.501 | |||
| Treynor Ratio | 23.39 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Capricor Stock Analysis
When running Capricor Therapeutics' price analysis, check to measure Capricor Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Capricor Therapeutics is operating at the current time. Most of Capricor Therapeutics' value examination focuses on studying past and present price action to predict the probability of Capricor Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Capricor Therapeutics' price. Additionally, you may evaluate how the addition of Capricor Therapeutics to your portfolios can decrease your overall portfolio volatility.